| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cellular response to virus | 1.28e-05 | 90 | 69 | 5 | GO:0098586 | |
| Domain | LRR | 5.25e-08 | 201 | 69 | 9 | PS51450 | |
| Domain | LRR_1 | 1.09e-07 | 219 | 69 | 9 | PF00560 | |
| Domain | LRR_8 | 2.18e-07 | 171 | 69 | 8 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 2.84e-07 | 177 | 69 | 8 | IPR003591 | |
| Domain | LRR_TYP | 2.84e-07 | 177 | 69 | 8 | SM00369 | |
| Domain | Leu-rich_rpt | 6.61e-07 | 271 | 69 | 9 | IPR001611 | |
| Domain | - | 2.68e-06 | 321 | 69 | 9 | 3.80.10.10 | |
| Domain | L_dom-like | 3.20e-06 | 328 | 69 | 9 | IPR032675 | |
| Domain | LRRCT | 5.67e-06 | 32 | 69 | 4 | PF01463 | |
| Domain | Cys-rich_flank_reg_C | 3.43e-04 | 90 | 69 | 4 | IPR000483 | |
| Domain | LRRCT | 3.43e-04 | 90 | 69 | 4 | SM00082 | |
| Domain | LRRNT | 4.74e-04 | 98 | 69 | 4 | IPR000372 | |
| Domain | LRRNT | 4.74e-04 | 98 | 69 | 4 | SM00013 | |
| Domain | Transglut_N | 4.76e-04 | 9 | 69 | 2 | PF00868 | |
| Domain | TRANSGLUTAMINASES | 4.76e-04 | 9 | 69 | 2 | PS00547 | |
| Domain | Transglutaminase_N | 4.76e-04 | 9 | 69 | 2 | IPR001102 | |
| Domain | Transglut_C | 4.76e-04 | 9 | 69 | 2 | PF00927 | |
| Domain | - | 4.76e-04 | 9 | 69 | 2 | 3.90.260.10 | |
| Domain | Gln_gamma-glutamylTfrase_euk | 4.76e-04 | 9 | 69 | 2 | IPR023608 | |
| Domain | Transglutaminase_AS | 4.76e-04 | 9 | 69 | 2 | IPR013808 | |
| Domain | ARM-like | 4.83e-04 | 270 | 69 | 6 | IPR011989 | |
| Domain | Transglutaminase_C | 5.94e-04 | 10 | 69 | 2 | IPR008958 | |
| Domain | TGc | 7.24e-04 | 11 | 69 | 2 | SM00460 | |
| Domain | Transglut_core | 7.24e-04 | 11 | 69 | 2 | PF01841 | |
| Domain | Transglutaminase-like | 7.24e-04 | 11 | 69 | 2 | IPR002931 | |
| Domain | - | 1.37e-03 | 222 | 69 | 5 | 1.25.10.10 | |
| Domain | ARM-type_fold | 1.57e-03 | 339 | 69 | 6 | IPR016024 | |
| Domain | TIR | 2.70e-03 | 21 | 69 | 2 | SM00255 | |
| Domain | TIR | 2.96e-03 | 22 | 69 | 2 | PF01582 | |
| Domain | - | 3.24e-03 | 23 | 69 | 2 | 3.40.50.10140 | |
| Domain | TIR | 3.52e-03 | 24 | 69 | 2 | PS50104 | |
| Domain | TIR_dom | 3.82e-03 | 25 | 69 | 2 | IPR000157 | |
| Pubmed | 5.89e-07 | 33 | 70 | 4 | 25064009 | ||
| Pubmed | Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells. | 3.99e-06 | 2 | 70 | 2 | 19887600 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 32810576 | ||
| Pubmed | Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists. | 3.99e-06 | 2 | 70 | 2 | 26255864 | |
| Pubmed | Toll-like receptor 3 (TLR3) signaling requires TLR4 Interactor with leucine-rich REPeats (TRIL). | 3.99e-06 | 2 | 70 | 2 | 21911501 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 34342515 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16368889 | ||
| Pubmed | Extracellular RNA Sensing Mediates Inflammation and Organ Injury in a Murine Model of Polytrauma. | 3.99e-06 | 2 | 70 | 2 | 37133342 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19445181 | ||
| Pubmed | Skewed endosomal RNA responses from TLR7 to TLR3 in RNase T2-deficient macrophages. | 3.99e-06 | 2 | 70 | 2 | 34161582 | |
| Pubmed | RNA receptors, TLR3 and TLR7, are potentially associated with SLE clinical features. | 3.99e-06 | 2 | 70 | 2 | 33650302 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 20309865 | ||
| Pubmed | Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands. | 3.99e-06 | 2 | 70 | 2 | 23019335 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 35063671 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26581984 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 27586271 | ||
| Pubmed | Fbxl18 targets LRRK2 for proteasomal degradation and attenuates cell toxicity. | 3.99e-06 | 2 | 70 | 2 | 27890708 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 27046485 | ||
| Pubmed | TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. | 3.99e-06 | 2 | 70 | 2 | 16105838 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 28339092 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 30906301 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16537810 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 35801751 | ||
| Pubmed | Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3. | 3.99e-06 | 2 | 70 | 2 | 25539593 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 27084119 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 20300788 | ||
| Pubmed | 4.29e-06 | 16 | 70 | 3 | 21292315 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 23425350 | ||
| Pubmed | Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7. | 1.20e-05 | 3 | 70 | 2 | 17981792 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 24445780 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 24692849 | ||
| Pubmed | Toll-like receptor polymorphisms and age-related macular degeneration. | 1.20e-05 | 3 | 70 | 2 | 18385087 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 28300057 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 22565312 | ||
| Pubmed | Cryo-EM structures of Toll-like receptors in complex with UNC93B1. | 1.20e-05 | 3 | 70 | 2 | 33432245 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 30321082 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 25126563 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 15210814 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 17675254 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 29290528 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 19559490 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 28544067 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 25008898 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 27399248 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 15634897 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 26603638 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 25309919 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 29947302 | ||
| Pubmed | Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis. | 1.20e-05 | 3 | 70 | 2 | 32999457 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 16111635 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 23761632 | ||
| Pubmed | In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C. | 1.20e-05 | 3 | 70 | 2 | 23489702 | |
| Pubmed | Toll-like receptors 3, 7, and 9 in Juvenile nasopharyngeal angiofibroma. | 1.20e-05 | 3 | 70 | 2 | 25912131 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 16935934 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 18021446 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 31481269 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 27405980 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 23628791 | ||
| Pubmed | Characterization of TLR-induced inflammatory responses in COPD and control lung tissue explants. | 1.20e-05 | 3 | 70 | 2 | 27729782 | |
| Pubmed | MAVS mediates a protective immune response in the brain to Rift Valley fever virus. | 1.20e-05 | 3 | 70 | 2 | 35584192 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 22490479 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 29768176 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 37020259 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 34211474 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 17452530 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 19451267 | ||
| Pubmed | Structural imaging in the presymptomatic stage of genetically determined parkinsonism. | 2.39e-05 | 4 | 70 | 2 | 20483373 | |
| Pubmed | TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes. | 2.39e-05 | 4 | 70 | 2 | 21844166 | |
| Pubmed | Painful pathways induced by TLR stimulation of dorsal root ganglion neurons. | 2.39e-05 | 4 | 70 | 2 | 21515789 | |
| Pubmed | Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. | 2.39e-05 | 4 | 70 | 2 | 16985170 | |
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 28416600 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 23179584 | ||
| Pubmed | Extracellular MicroRNAs Induce Potent Innate Immune Responses via TLR7/MyD88-Dependent Mechanisms. | 2.39e-05 | 4 | 70 | 2 | 28768728 | |
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 29777026 | ||
| Pubmed | The Src-ZNRF1 axis controls TLR3 trafficking and interferon responses to limit lung barrier damage. | 2.39e-05 | 4 | 70 | 2 | 37158982 | |
| Pubmed | Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. | 2.39e-05 | 4 | 70 | 2 | 21990957 | |
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 33138336 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 26363072 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 21148036 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 23369718 | ||
| Pubmed | Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus. | 2.39e-05 | 4 | 70 | 2 | 20697102 | |
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 21538349 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 20451253 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 36271773 | ||
| Pubmed | 3.98e-05 | 5 | 70 | 2 | 21525388 | ||
| Pubmed | 3.98e-05 | 5 | 70 | 2 | 23325805 | ||
| Pubmed | 3.98e-05 | 5 | 70 | 2 | 17897860 | ||
| Pubmed | Expression of soluble Toll-like receptors in pleural effusions. | 3.98e-05 | 5 | 70 | 2 | 20819670 | |
| Pubmed | 3.98e-05 | 5 | 70 | 2 | 23290966 | ||
| Pubmed | 3.98e-05 | 5 | 70 | 2 | 19426550 | ||
| Pubmed | IFN type I and type II independent enhancement of B cell TLR7 expression by natural killer cells. | 3.98e-05 | 5 | 70 | 2 | 22636319 | |
| Pubmed | Macrophages recognize streptococci through bacterial single-stranded RNA. | 3.98e-05 | 5 | 70 | 2 | 21164516 | |
| Pubmed | TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. | 3.98e-05 | 5 | 70 | 2 | 22821982 | |
| Pubmed | 3.98e-05 | 5 | 70 | 2 | 16286015 | ||
| Pubmed | Cultured human melanocytes express functional toll-like receptors 2-4, 7 and 9. | 3.98e-05 | 5 | 70 | 2 | 19740627 | |
| Pubmed | 3.98e-05 | 5 | 70 | 2 | 25188232 | ||
| Pubmed | 3.98e-05 | 5 | 70 | 2 | 25756897 | ||
| Pubmed | TLR agonists downregulate H2-O in CD8alpha- dendritic cells. | 3.98e-05 | 5 | 70 | 2 | 21918198 | |
| Pubmed | Variable requirement of dendritic cells for recruitment of NK and T cells to different TLR agonists. | 3.98e-05 | 5 | 70 | 2 | 17339488 | |
| Pubmed | 3.98e-05 | 5 | 70 | 2 | 27277333 | ||
| GeneFamily | Transglutaminases | 2.25e-04 | 9 | 46 | 2 | 773 | |
| GeneFamily | CD molecules|Toll like receptors | 2.81e-04 | 10 | 46 | 2 | 948 | |
| GeneFamily | Parkinson disease associated genes | 7.43e-04 | 16 | 46 | 2 | 672 | |
| GeneFamily | Interferons | 2.99e-03 | 32 | 46 | 2 | 598 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1 | 9.71e-05 | 77 | 66 | 4 | GSM605827_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-2 | 1.18e-04 | 81 | 66 | 4 | GSM538260_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2 | 1.18e-04 | 81 | 66 | 4 | GSM538234_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lu, CD11chi CD11b low CD103+ MHCII+ SiglecF-, Lung, avg-3 | 1.24e-04 | 82 | 66 | 4 | GSM538231_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-2 | 1.43e-04 | 85 | 66 | 4 | GSM538258_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | 1.56e-04 | 87 | 66 | 4 | GSM538252_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-.Th, CD11b-FITC CD4-PE MHCII-APC CD11c-eFluor780 CD8-eF, Thymus, avg-3 | 1.56e-04 | 87 | 66 | 4 | GSM605831_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | 1.56e-04 | 87 | 66 | 4 | GSM538255_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Th, CD11b-FITC CD4-PE MHCII-APC CD11c-eFluor780 CD8-eF, Thymus, avg-3 | 1.56e-04 | 87 | 66 | 4 | GSM605828_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lu, MHCII+ CD11c+ CD103+ CD11b, Lung, avg-2 | 2.46e-04 | 402 | 66 | 7 | GSM854241_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2 | 2.74e-04 | 409 | 66 | 7 | GSM538234_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Th, CD11b-FITC CD4-PE MHCII-APC CD11c-eFluor780 CD8-eF, Thymus, avg-3 | 2.86e-04 | 412 | 66 | 7 | GSM605828_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-.Th, CD11b-FITC CD4-PE MHCII-APC CD11c-eFluor780 CD8-eF, Thymus, avg-3 | 2.90e-04 | 413 | 66 | 7 | GSM605831_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lu, CD11chi CD11b low CD103+ MHCII+ SiglecF-, Lung, avg-3 | 3.40e-04 | 424 | 66 | 7 | GSM538231_500 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.49e-07 | 190 | 70 | 6 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.84e-07 | 192 | 70 | 6 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Alcam_(Alcam)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.99e-06 | 142 | 70 | 5 | 6a656d28c9f5dfb03a3a2d908cf2edbe0a5b1206 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.99e-06 | 142 | 70 | 5 | 671ba8869db7a6dc69fd1caf0e561f15a312b170 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.99e-06 | 142 | 70 | 5 | 3557084150670fd2e2634fc674f228ab85181b59 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Alcam_(Alcam)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.99e-06 | 142 | 70 | 5 | a3d1f4b570b75402171e38c5a7c88e2896520c8f | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.67e-06 | 148 | 70 | 5 | 223d6a640f3c34e73646a615593b9c0b4a4cbd6f | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-06 | 153 | 70 | 5 | cb144b8c487286384b47fdff88ff98fcf0508899 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.89e-06 | 157 | 70 | 5 | 5aee90ad7aaa65fdabc23597451da5e48db8f4e6 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-06 | 158 | 70 | 5 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-06 | 168 | 70 | 5 | ce5e92a1df3acfa5cd8d5a134e4af231dc592a13 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-06 | 168 | 70 | 5 | 22c89d4eb44573f6301069ec7ca7cbd0dd958403 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.84e-06 | 173 | 70 | 5 | 70c0c13febd28b395fb3171ec8d7fbbc6c9d4eb7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.07e-06 | 174 | 70 | 5 | e0de0a14319be1a115e5be05d6f9b562e7b32c4a | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.51e-06 | 180 | 70 | 5 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-05 | 184 | 70 | 5 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.14e-05 | 187 | 70 | 5 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.17e-05 | 188 | 70 | 5 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 188 | 70 | 5 | ab6fa1beff91584d9303c2a33735de89aae8d5cd | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 1.20e-05 | 189 | 70 | 5 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 1.23e-05 | 190 | 70 | 5 | 2592765016f291565697265800a232b2edef3792 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 1.23e-05 | 190 | 70 | 5 | 9fc763d65470ba8858b973689c4d4358faab7dd3 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 1.27e-05 | 191 | 70 | 5 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 194 | 70 | 5 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 196 | 70 | 5 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 197 | 70 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.54e-05 | 199 | 70 | 5 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 1.58e-05 | 200 | 70 | 5 | cbe667eda1af222467df8bfa157aa22df488f133 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.58e-05 | 200 | 70 | 5 | 808571d74bb5c4d765ff13fc9393f88020d4e90d | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-05 | 200 | 70 | 5 | ed785a6d08ca2b350dc3307b587eadfb2886d1f9 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.85e-05 | 120 | 70 | 4 | a6d0406a174d46ce06b41280292931954af88a59 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Gad2-Inhibitory_Neuron.Gad1Gad2.Gad2-Kcnc3_(GABAergic,_K/Na_Channel_State)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.99e-05 | 53 | 70 | 3 | a58b0b1c9991cfebf20e206a129b79f494785138 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Gad2-Inhibitory_Neuron.Gad1Gad2.Gad2-Kcnc3_(GABAergic,_K/Na_Channel_State)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.99e-05 | 53 | 70 | 3 | e90685a7c6ef223783b1c1a6b1896fd566449422 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Gad2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.99e-05 | 53 | 70 | 3 | 5ad1a5c5c9a1dc66dd7e6de6edbee0176678966c | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.71e-05 | 148 | 70 | 4 | cb9365663f9cba35d47b5dd9079f42e88b70d915 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-05 | 148 | 70 | 4 | bbf4933582b50b3412c805de5ed137107c996236 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-05 | 148 | 70 | 4 | 6543860e3207a7de92a35bb6004be51287582f7a | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-05 | 148 | 70 | 4 | 79e376503a3f9504a1ec5af4a60a09cc80e19059 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.94e-05 | 149 | 70 | 4 | 48fca6ae33d7722c024b43ce04f4dbce7b6b424b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.41e-05 | 151 | 70 | 4 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 151 | 70 | 4 | ced4f7ee377a23a804ae6fde624e8b55b79f1fd8 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 151 | 70 | 4 | b52bb3b88e9a6473f571053537b8beb418678539 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.65e-05 | 152 | 70 | 4 | 7e686721b95c837f2b0d5116927c8ecacef055ee | |
| ToppCell | COVID-19-Heart-Adipocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.90e-05 | 153 | 70 | 4 | 93958bd9c951222ba5b740d1cb83fd5d78a10e1e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 154 | 70 | 4 | 1e32969bee810adaf2d560f0824a16227df513d8 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.04e-04 | 155 | 70 | 4 | 9f937ae48767fdcf1a944af4de0530d9c0ab441d | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 156 | 70 | 4 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 157 | 70 | 4 | 9d4308312301cb922f156a7b6aededc9e1c62807 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 158 | 70 | 4 | 90ca742739a208d457db087655ba3d1c18a9da57 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 159 | 70 | 4 | 323cb4a2416d2e6bff0a3f225d2edeae9ab7dc76 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 160 | 70 | 4 | 830e3ef8c9708d25872c3052a0b2682fa9372111 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 160 | 70 | 4 | 8dae9b0cf90a09acb196223f45a14680102630b2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-D_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-04 | 160 | 70 | 4 | ac5d573c135d66d6adddd42dfddd9d3e01532172 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-D_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-04 | 160 | 70 | 4 | b81d218c20fe37921cf3c6c7db2da3bfd367230a | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.18e-04 | 160 | 70 | 4 | bb1bb3673059768c0ea0160d29fff127f3a4ecb4 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-04 | 160 | 70 | 4 | dee756a2dc9725520d439e7273c489c2284015d8 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.18e-04 | 160 | 70 | 4 | 76f49b8b4450fa8acd36326bfa36a5d1f4bd95fb | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 160 | 70 | 4 | 1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 162 | 70 | 4 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 162 | 70 | 4 | 7d43d59531cbefe3ac94953b7faf7156b2a31441 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 166 | 70 | 4 | 019d365df44c3bbd88c1f4bdceb3de0ff76d3e8d | |
| ToppCell | mild-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.39e-04 | 167 | 70 | 4 | 0811f7559c2a7151693771e52e14af3978997118 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.45e-04 | 169 | 70 | 4 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | COVID-19-Heart-Adipocyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 169 | 70 | 4 | bd39f85b48207955f80ca120a11e15a0124117b9 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 169 | 70 | 4 | 305cedbd97059029d7d2a248a8a4b6cfe281aa54 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 169 | 70 | 4 | 149a4f83da15bdeb170e980fb5b5b1af89ae07a6 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.49e-04 | 170 | 70 | 4 | d0ed3a8a7ad96c05641ec409b0a69c4fb094893c | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 171 | 70 | 4 | 8a0c08f0aa3a80cd6346c81deb242e430ebd897b | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 70 | 4 | f814b6134ad608015765399d54cc1e5e1873ed34 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 70 | 4 | 1f335ccb92b22d0412954e8fc3af212f96410b67 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 70 | 4 | cfcfa7eeff1805bedf10a3c07826459914c3e872 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 70 | 4 | a125ac2db9c8ece95970a93aa6f7918d1dcef886 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 70 | 4 | bb96c896d125e10b71e94e2bdad243899045af5c | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 70 | 4 | a5344760b10ecdc0101f78b93b8fc0f8107068c5 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 70 | 4 | 6aab59add5b180cee0ca31179c620e89d352d5c1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 70 | 4 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 174 | 70 | 4 | 2f4bc0275cbcaa830d04a4c76e042456908d2277 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 174 | 70 | 4 | 01eff218e71a04201189a0313aaf91437fffed95 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 174 | 70 | 4 | f0f6d135e1fb4c15022be103b00d8d5456515a18 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 175 | 70 | 4 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 176 | 70 | 4 | f7d8eb90489a6d22240179abeb0aa16ac24615d3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 176 | 70 | 4 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Promyelocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.70e-04 | 176 | 70 | 4 | ee33d7077a92c1fd371081e7c990c7266e711957 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 177 | 70 | 4 | 0d1c39e99144fdb9c7f6f98a1ade41c73db45b65 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 178 | 70 | 4 | ee674e379ee57e40eb2560ff5ed4c13d8db7ed9d | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 178 | 70 | 4 | da1695a936dbe3ca9ee3fb28ceb60511c47b35f8 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-04 | 178 | 70 | 4 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 178 | 70 | 4 | 6c45bf197d6c1be0ef7d3a644c0062acf1e24e4d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 178 | 70 | 4 | cd85dcefe94ee742db64b63e105e13532321894a | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 178 | 70 | 4 | 580fc1d45b82010c665a313b2e7a21e0116819ef | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-04 | 179 | 70 | 4 | c9f45cfea0ceb0cdc31bcfd123aeab69aeb35c35 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-04 | 180 | 70 | 4 | cc31d2cd06161300b91b17a67bb432b75f0d719b | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.85e-04 | 180 | 70 | 4 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.89e-04 | 181 | 70 | 4 | 57f20341c3e9f9f6ed5b6c181605ad35bae91414 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.89e-04 | 181 | 70 | 4 | 47dce04db3392333eb2f7b9b24c32e6740d2d02f | |
| ToppCell | Control-Myeloid-Alveolar_macrophages|Control / group, cell type (main and fine annotations) | 1.89e-04 | 181 | 70 | 4 | 8d2102c8c86c59a82610f26f90946b290552e666 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.89e-04 | 181 | 70 | 4 | 19103221c3a5a16b16378348004b2c50caee4f01 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.89e-04 | 181 | 70 | 4 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-04 | 182 | 70 | 4 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.93e-04 | 182 | 70 | 4 | 94d061b7b5ebbfc564c644bc8b2d52341927145d | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; PC3; HT_HG-U133A | 2.55e-06 | 198 | 70 | 7 | 7384_DN | |
| Disease | complement component C6 measurement | 3.90e-04 | 13 | 67 | 2 | EFO_0020281 | |
| Disease | caffeine measurement | 5.23e-04 | 15 | 67 | 2 | EFO_0021177 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 6.76e-04 | 17 | 67 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | amino acid measurement | 8.64e-04 | 678 | 67 | 7 | EFO_0005134 | |
| Disease | Nerve Degeneration | 9.03e-04 | 83 | 67 | 3 | C0027746 | |
| Disease | Parkinson Disease | 9.67e-04 | 85 | 67 | 3 | C0030567 | |
| Disease | Liver carcinoma | 1.03e-03 | 507 | 67 | 6 | C2239176 | |
| Disease | blood pressure | 1.14e-03 | 22 | 67 | 2 | EFO_0004325 | |
| Disease | Parkinson disease | 1.14e-03 | 22 | 67 | 2 | cv:C0030567 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 1.36e-03 | 24 | 67 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | Disorder of eye | 1.39e-03 | 212 | 67 | 4 | C0015397 | |
| Disease | anogenital venereal wart (is_marker_for) | 1.59e-03 | 26 | 67 | 2 | DOID:11168 (is_marker_for) | |
| Disease | Autosomal Dominant Parkinsonism | 1.85e-03 | 28 | 67 | 2 | C0752098 | |
| Disease | Autosomal Dominant Juvenile Parkinson Disease | 1.85e-03 | 28 | 67 | 2 | C0752097 | |
| Disease | Parkinsonism, Experimental | 1.85e-03 | 28 | 67 | 2 | C0752101 | |
| Disease | Autosomal Recessive Parkinsonism | 1.85e-03 | 28 | 67 | 2 | C0752100 | |
| Disease | Familial Juvenile Parkinsonism | 1.85e-03 | 28 | 67 | 2 | C0752104 | |
| Disease | Ramsay Hunt Paralysis Syndrome | 1.85e-03 | 28 | 67 | 2 | C0242423 | |
| Disease | PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE | 1.85e-03 | 28 | 67 | 2 | C1868675 | |
| Disease | Ciliopathies | 2.03e-03 | 110 | 67 | 3 | C4277690 | |
| Disease | Parkinsonism, Juvenile | 2.12e-03 | 30 | 67 | 2 | C0752105 | |
| Disease | malate measurement | 2.12e-03 | 30 | 67 | 2 | EFO_0010508 | |
| Disease | Parkinsonian Disorders | 2.12e-03 | 30 | 67 | 2 | C0242422 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 2.26e-03 | 31 | 67 | 2 | C1335167 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALTCSDDRNLLNRLL | 891 | Q9UKU6 | |
| CAASRLLQLLLQLLL | 6 | Q10588 | |
| QLRLCFTQAARTSLL | 11 | Q9HB65 | |
| SLAASLLRLSLYNNC | 1041 | P33076 | |
| CSALRQALLLLAAAA | 6 | Q8NER5 | |
| LAANRTCLRFLLLSA | 306 | Q68CP9 | |
| TLALRQRLISSSCRL | 11 | Q8IUZ5 | |
| LLASLRASILARDCA | 91 | Q96QP1 | |
| ACRLARLLVTQANRL | 96 | Q8N1W1 | |
| SLSLGQRQLLCLARA | 1381 | Q5T3U5 | |
| QRQLLCLARALLTDA | 1386 | Q5T3U5 | |
| RNGLSRLCQSRTALS | 51 | Q96RG2 | |
| LLLSQSRQRIVCLNS | 341 | Q14667 | |
| RAQRRLSGLSVLLLC | 276 | Q9GZN0 | |
| ADLARCAPRLQSLNL | 146 | Q8N1G4 | |
| LLSDRCLQVLNRHLT | 666 | Q9NRD8 | |
| RLRALNNCLSHILAV | 236 | Q8NH59 | |
| LLFLALRSIRCLRNV | 136 | Q13324 | |
| QLCRSQSLLLRSSTR | 506 | Q5TB30 | |
| RQRVLRASASLLSQC | 1066 | Q2M1P5 | |
| LRRLALDVANNSICL | 791 | Q5S007 | |
| RCLLDSDSRALLNQL | 761 | Q96CW5 | |
| LLTLRALQELDLTAC | 71 | Q8WV35 | |
| CRKLRTLLLGDNQLS | 721 | Q6NSJ5 | |
| CLLLAAATQLSRQQS | 11 | Q9UKZ9 | |
| SNSSLRRRLILANCD | 401 | Q13219 | |
| TNLLLTRTLSSCLLN | 521 | Q8TAG9 | |
| LLRALATCHALSRLQ | 551 | Q9NQ11 | |
| LLRRAAVACLRQLAQ | 1081 | Q9P2D3 | |
| QRLVCSLSLNRFRLA | 396 | Q8NFQ6 | |
| LLELLASALLALCSR | 186 | O95873 | |
| ALAGLLSRLICQRLQ | 346 | Q9P218 | |
| AALRIANCKLFRLQL | 571 | Q9H2C0 | |
| LSLDCNLLNVHLRRV | 26 | Q9P0W0 | |
| NLFRLLTRDLNCVAS | 181 | Q8IZJ0 | |
| ASLRVRLCDLLSHLQ | 56 | Q96LW7 | |
| RQLARSCLDLNTISQ | 186 | Q6ZN28 | |
| SELQATRLLCLRSLL | 121 | Q17RN3 | |
| AARNGLLLLNLLLCN | 866 | Q8IWT3 | |
| RLLLLQCLLAAARPS | 16 | Q6PCB8 | |
| QELPRLLSAACRLQL | 1176 | P49327 | |
| LRCISLTNLALSRRS | 141 | Q0D2K5 | |
| LVCSHRALRQLAQSL | 126 | Q4U2R8 | |
| RSLCLVTSLELLNLN | 226 | A6NM36 | |
| LALASQARLAECLRR | 391 | O15547 | |
| LRADSQRRAALCALN | 1171 | A6NGG8 | |
| LRLNSVSNLQCIHLL | 1026 | Q9Y283 | |
| LLLTSICDNSQLLRA | 151 | Q8ND04 | |
| ITLTDAQRLCNALLR | 221 | P12757 | |
| RLCSQLLTSHQNLLR | 2596 | Q8NF91 | |
| CAAALAAILTRLREN | 386 | Q2TB90 | |
| LSVCERLNLALSLSL | 321 | Q15270 | |
| CQLLARLRHLRSLSL | 406 | Q96ME1 | |
| CQLALELLASAARLL | 206 | Q9BY78 | |
| SLRRSIFINLLQQIC | 271 | Q7Z745 | |
| FSSALCAARLLRQRL | 86 | Q96GD0 | |
| LSICLSILDRSLNFR | 186 | Q08188 | |
| AQCSFILLLSIIRAR | 6 | Q6URK8 | |
| LRSCLLISVASLNFL | 111 | Q9NUD9 | |
| ELRAASALNRLLVLC | 81 | Q8WUH2 | |
| LCLELANTSIRNLSL | 241 | O15455 | |
| NSACLHLRKLLLLSR | 141 | A6NGC4 | |
| INTNLRRDALLHCLT | 156 | Q6P1M0 | |
| NRVLLSNLQRCDLAS | 356 | O94964 | |
| RLLAAFLLLAAQVAC | 11 | Q8TCT7 | |
| RLRELSLRNNALSAL | 326 | Q7L0X0 | |
| SRQACLAASLALALN | 86 | Q8NEB5 | |
| ATDCVRLSLQNLSRL | 261 | Q6ZS81 | |
| TQLLTLILSYNRLRC | 801 | O94813 | |
| ERLSNCSRSLKNLIL | 716 | Q9NYK1 | |
| EASSCAVNLVLRLRN | 446 | Q9UEW8 | |
| LRLALCLANLTSRAQ | 511 | O95932 | |
| QRALLANALTSALRL | 56 | P57088 | |
| VLLCQLLNNLRAHSI | 41 | Q9UKW4 | |
| LRSVSAQIRLLFCAR | 236 | O15399 |